Ventricular assist device in severe heart failure - Effects on cytokines, complement and body weight

被引:46
作者
Clark, AL
Leobe, M
Potapov, EV
Egerer, K
Knosalla, C
Hetzer, R
Anker, SD
机构
[1] Castle Hill Hosp, Dept Acad Cardiol, Kingston Upon Hull HU16 5JQ, N Humberside, England
[2] Deutsch Herzzentrum Berlin, Dept Thorac & Cardiovasc Surg, Berlin, Germany
[3] MDC Berlin, Franz Volhard Klin, Charite, Berlin, Germany
[4] Natl Heart & Lung Inst, Dept Cardiac Med, London SW3 6LY, England
关键词
chronic heart failure; ventricular assist device; cytokines; tumour necrosis factor alpha;
D O I
10.1053/euhj.2001.2693
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Inflammatory and immune activation and body wasting are important features of end-stage chronic heart failure. It is not known whether restoration of cardiac output by assist device implantation can improve these abnormalities. Methods We studied 48 patients (39 males; age 45 +/-2 years) with NYHA class IV heart failure. All patients underwent ventricular assist device implantation for endstage heart failure as a bridge to cardiac transplantation. Plasma levels Of tumour necrosis factor alpha, and its receptors, interleukin-6, elastase, activated complement, and soluble CD14 receptors were measured at the time of operation and in survivors at I week (n=46), 40 days (n=35) and 90 days (n=26). Follow-Lip was for a minimum of I year. Results One-year survival was 35% (95% Cl: 22-49%). Body mass index was the only predictor of survival (body mass index > 25 (n=16); survival 63 (39-86)%; body mass index < 25 (n=32), survival 22 (7.5-36)%: P=0.003). Tumour necrosis factor alpha fell from 9.66 +/-1.33 pg.ml(-1) to 4.2 +/-1.0 at I week (P=0.008), but returned to preoperative levels at 90 days. Interleukin-6, activated complement and elastase fell progressively to 40 days, but were rising at 90 days. There was no change in tumour necrosis factor receptor. There was a gradual rise in CD14 (3.99 +/-0.15 mug.ml(-1) at baseline, 5.02 +/-0.39 at 90 days, P=0.006). After surgery, body weight fell from 80 +/-2 to 73 +/-2 kg by I month (P <0.001) and to 72 +/-2 kg at 90 days. Conclusions Ventricular assist device implantation results in a short-term fall in tumour necrosis factor alpha and interleukin-6, but no change in CD14 or tumour necrosis factor receptor, suggesting that the pathophysiological process resulting in inflammation was not altered by left ventricular assist device implantation. Low body mass index is related to poor outcome after assist device implantation, and no weight gain. (C) 2001 The European Society of Cardiology.
引用
收藏
页码:2275 / 2283
页数:9
相关论文
共 35 条
  • [1] Tumor necrosis factor and steroid metabolism in chronic heart failure: Possible relation to muscle wasting
    Anker, SD
    Clark, AL
    Kemp, M
    Salsbury, C
    Teixeira, MM
    Hellewell, PG
    Coats, AJS
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (04) : 997 - 1001
  • [2] Elevated soluble CD 14 receptors and altered cytokines in chronic heart failure
    Anker, SD
    Egerer, KR
    Volk, HD
    Kox, WJ
    PooleWilson, PA
    Coats, AJS
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (10) : 1426 - &
  • [3] Wasting as independent risk factor for mortality in chronic heart failure
    Anker, SD
    Ponikowski, P
    Varney, S
    Chua, TP
    Clark, AL
    WebbPeploe, KM
    Harrington, D
    Kox, WJ
    PooleWilson, PA
    Coats, AJS
    [J]. LANCET, 1997, 349 (9058) : 1050 - 1053
  • [4] Anker SD, 1997, CIRCULATION, V96, P526
  • [5] Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device
    Ankersmit, HJ
    Tugulea, S
    Spanier, T
    Weinberg, AD
    Artrip, JH
    Burke, EM
    Flannery, M
    Mancini, D
    Rose, EA
    Edwards, NM
    Oz, MC
    Itescu, S
    [J]. LANCET, 1999, 354 (9178) : 550 - 555
  • [6] Elevated circulating levels of C-C chemokines in patients with congestive heart failure
    Aukrust, P
    Ueland, T
    Müller, F
    Andreassen, AK
    Nordoy, I
    Aas, H
    Kjekshus, J
    Simonsen, S
    Froland, SS
    Gullestad, L
    [J]. CIRCULATION, 1998, 97 (12) : 1136 - 1143
  • [7] Catabolism in chronic heart failure
    Berry, C
    Clark, AL
    [J]. EUROPEAN HEART JOURNAL, 2000, 21 (07) : 521 - 532
  • [8] LEVELS OF T-LYMPHOCYTE SUBPOPULATIONS, INTERLEUKIN-1-BETA, AND SOLUBLE INTERLEUKIN-2 RECEPTOR IN ACUTE MYOCARDIAL-INFARCTION
    BLUM, A
    SCLAROVSKY, S
    REHAVIA, E
    SHOHAT, B
    [J]. AMERICAN HEART JOURNAL, 1994, 127 (05) : 1226 - 1230
  • [9] Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α
    Bryant, D
    Becker, L
    Richardson, J
    Shelton, J
    Franco, F
    Peshock, R
    Thompson, M
    Giroir, B
    [J]. CIRCULATION, 1998, 97 (14) : 1375 - 1381
  • [10] CYTOKINE RESPONSES TO CARDIOPULMONARY BYPASS WITH MEMBRANE AND BUBBLE OXYGENATION
    BUTLER, J
    CHONG, GL
    BAIGRIE, RJ
    PILLAI, R
    WESTABY, S
    ROCKER, GM
    [J]. ANNALS OF THORACIC SURGERY, 1992, 53 (05) : 833 - 838